Business News

Advent International, Warburg Pincus Complete $4.25 Billion Acquisition of Baxter’s BioPharma Solutions Business

October 02, 2023

The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.

Sartorius and SPARTA Biodiscovery Partner on Novel Nanoparticle Analysis Platform

September 29, 2023

Under the partnership, Sartorius will leverage SPARTA Biodiscovery’s technology to accelerate development of nanoparticles used for drug delivery.

MilliporeSigma Opens Two New GMP Manufacturing Sites in Germany for mRNA Production

September 28, 2023

With the two new GMP-grade mRNA manufacturing sites in Germany, MilliporeSigma can now offer fully integrated mRNA services.

Genentech Partners with Orionis Biosciences to Discover and Develop Molecular Glue Class Medicines

September 20, 2023

Under the collaboration, Orionis will receive $47 million upfront to leverage its Allo-Glue platform to discover small-molecule monovalent glues.

CN Bio and LifeNet Health LifeSciences Partner to Supply Pre-Validated Cells

September 20, 2023

CN Bio and LifeNet Health LifeSciences have teamed up to provide direct access to a portfolio of highly characterized hepatic cells for the creation of advanced liver-on-a-chip assays.

Illumina Establishes New Center in India to Expand Genomics Capabilities

September 07, 2023

Illumina’s new solutions center in Bengaluru, India, will expand access to genomics in the country.

Bristol Myers Squibb Joins Cellares Program Focused on Automated Cell Therapy Manufacturing as Cellares is Launched as First IDMO

August 31, 2023

Bristol Myers Squibb has joined Cellares’ Technology Adoption Partnership program just as Cellares launches operations as an integrated development and manufacturing organization.

Three-Way Collaboration Between Rentschler Biopharma, CGT Catapult, and Refeyn Aims to Improve PAT for Gene Therapy Manufacturing

August 29, 2023

Rentschler Biopharma, CGT Catapult, and Refeyn aim to use automated and digital technologies to improve AAV manufacturing for gene therapies.

Danaher to Acquire Abcam in $5.7 Billion Deal

August 29, 2023

Danaher intends to acquire Abcam, a provider of life sciences assays and reagents, for $5.7 billion.

Royalty Pharma Places $500 Million Bet on Ferring Gene Therapy

August 24, 2023

Royalty Pharma agreed to spend up to $500 million for a 5.1 to 8% royalty on net sales of Ferring’s gene therapy adstiladrin (nadofaragene firadenovec-vcng).